Enzychem Lifesciences Corp. (183490) Price & Analysis

― Followers

183490 Stock Chart & Stats

₩990.00

₩0.00(0.00%)

Aug 18, 2026

―

Day’s Range― - ―

52-Week Range₩937.00 - ₩1,766.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)0.00

Market Cap

₩76.86B

Enterprise Value-₩18.22K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-0.07

Next Earnings

Nov 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding84,640,236

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

183490 FAQ

What was Enzychem Lifesciences Corp.’s price range in the past 12 months?

Enzychem Lifesciences Corp. lowest stock price was ₩937.00 and its highest was ₩1766.00 in the past 12 months.

What is Enzychem Lifesciences Corp.’s market cap?

Enzychem Lifesciences Corp.’s market cap is ₩76.86B.

When is Enzychem Lifesciences Corp.’s upcoming earnings report date?

Enzychem Lifesciences Corp.’s upcoming earnings report date is Nov 12, 2026 which is in 85 days.

How were Enzychem Lifesciences Corp.’s earnings last quarter?

Currently, no data Available

Is Enzychem Lifesciences Corp. overvalued?

According to Wall Street analysts Enzychem Lifesciences Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Enzychem Lifesciences Corp. pay dividends?

Enzychem Lifesciences Corp. does not currently pay dividends.

What is Enzychem Lifesciences Corp.’s EPS estimate?

Enzychem Lifesciences Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Enzychem Lifesciences Corp. have?

Enzychem Lifesciences Corp. has 84,640,236 shares outstanding.

What happened to Enzychem Lifesciences Corp.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Enzychem Lifesciences Corp.?

Currently, no hedge funds are holding shares in KR:183490

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Enzychem Lifesciences Corp.

Enzychem Lifesciences Corporation specializes in the creation and manufacturing of active pharmaceutical ingredients (APIs) and specialized nutritional products. Its operations also extend to the production of a diverse range of animal health products, comprising tablets, capsules, liquid formulations (syrups, injections, solutions), and topical applications (ointments), intended for the diagnosis and prophylactic treatment of numerous veterinary ailments. Furthermore, Enzychem is vigorously pursuing the development of novel therapeutic agents for conditions such as neutropenia caused by chemotherapy, oral mucositis associated with chemo-radiation therapy, asthma, psoriasis, and rheumatoid arthritis, among other debilitating illnesses.